Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection.

MLA

Roger, Thierry, et al. “Histone Deacetylase Inhibitors Impair Innate Immune Responses to Toll-like Receptor Agonists and to Infection.” Blood, vol. 117, no. 4, Jan. 2011, pp. 1205–17. EBSCOhost, https://doi.org/10.1182/blood-2010-05-284711.

APA

Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A.-L., Reymond, M. K., Miconnet, I., Schrenzel, J., François, P., & Calandra, T. (2011). Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood, 117(4), 1205–1217. https://doi.org/10.1182/blood-2010-05-284711

Chicago

Roger, Thierry, Jérôme Lugrin, Didier Le Roy, Geneviève Goy, Matteo Mombelli, Thibaud Koessler, Xavier C Ding, et al. 2011. “Histone Deacetylase Inhibitors Impair Innate Immune Responses to Toll-like Receptor Agonists and to Infection.” Blood 117 (4): 1205–17. doi:10.1182/blood-2010-05-284711.